Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. WellSpan Medical Oncology & Hematology - Hanover

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

WellSpan Medical Oncology & Hematology – Hanover is a community-based oncology care facility located at 671 Wilson Avenue, Hanover, Pennsylvania, and is part of the WellSpan Health network. The site provides specialized medical oncology and hematology services, supporting patients with a range of cancers and blood disorders through individualized treatment planning and coordinated care. Its services include advanced cancer treatments such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy, with support from oncology specialists and nurse navigators. Through the broader WellSpan Cancer Institute, the facility is connected to a multidisciplinary cancer care network that collaborates with Johns Hopkins Medicine’s Kimmel Cancer Center, offering access to specialized expertise and clinical trial opportunities.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Medical clinic

Business Subcategory

Source: Google. Medical clinic
Source: Google. Oncologist
Source: Trial-derived.
41Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
33Active Trials
Source: Trial-derived.
8Completed Trials
Source: Trial-derived.
226Unique Conditions
Source: Trial-derived.
9Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Stage IIIB Lung Cancer AJCC v8 (4)Source: Trial-derived. Stage IV Lung Cancer AJCC v8 (4)Source: Trial-derived. Clinical Stage III Cutaneous Melanoma AJCC v8 (3)Source: Trial-derived. Clinical Stage IV Cutaneous Melanoma AJCC v8 (3)Source: Trial-derived. Lung Non-Squamous Non-Small Cell Carcinoma (3)Source: Trial-derived. Recurrent Lung Non-Squamous Non-Small Cell Carcinoma (3)Source: Trial-derived. Recurrent Ovarian Carcinoma (3)Source: Trial-derived. Stage IB Lung Non-Small Cell Carcinoma AJCC v7 (3)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (41)Source: Trial-derived. NRG Oncology (11)Source: Trial-derived. SWOG Cancer Research Network (3)Source: Trial-derived. Alliance for Clinical Trials in Oncology (2)Source: Trial-derived. Canadian Cancer Trials Group (2)Source: Trial-derived. Cancer and Leukemia Group B (1)Source: Trial-derived. NCIC Clinical Trials Group (1)Source: Trial-derived. North Central Cancer Treatment Group (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. Echocardiography
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Apheresis
Source: AI-inferred. Blood transfusion service

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. HIV viral-load testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. ALK rearrangement testing
Source: AI-inferred. Blood methemoglobin measurement
Source: AI-inferred. CD4 T-cell enumeration
Source: AI-inferred. Conventional cytogenetic analysis (karyotyping/FISH)